2024-515592-35-00招募中1 期
Study of BGB-11417 in Patients with Mature B Cell Malignancies
Beigene Ltd.14 个研究点 分布在 2 个国家目标入组 69 人开始时间: 2024年10月10日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 69
- 试验地点
- 14
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
BeOne Medical Officer
Scientific
Beigene Ltd.
研究点 (14)
Loading locations...
相似试验
招募中
2 期
Evaluation of the efficacy and safety of Rituximab in patients with Amyotrophic Lateral Sclerosis (ALS)2022-502743-35-00Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.52
已完成
1 期
Phase I Study of RO5541077 in Patients with B cell Non-Hodgkin s LymphomajRCT2080222529Chugai Pharmaceutical Co., Ltd.18
招募中
3 期
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple MyelomaMultiple MyelomaNCT07258511Janssen Research & Development, LLC400
撤回
1 期
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT.graft-versus-host disease2024-517002-28-00Red De Apoyo A La Investigacion Clinica En Hematologia Y Hemoterapia S.L., Vall D Hebron Institute Of Oncology8
已完成
不适用
The function and composition of B cells in patients with Glioblastoma treated with and without Dexamethasone10029211GlioblastomaBrain TumorNL-OMON49155Vrije Universiteit Medisch Centrum20